Kimia Biosciences Limited is an India-based company, which is engaged in the manufacturing of bulk drugs addressing various high-potential therapeutic segments. The Company provides its products under various categories: Commercial Active Pharmaceutical Ingredients (APIs), and Commercial KSMs, Intermediates and Reagents. The Company's Commercial-APIs products include Acotiamide Hydrochloride Hydrate, Azelnidipine, Benfotiamine, Benidipine Hydrochloride, Citicoline Sodium, Gliclazide, Dapagliflozin Propanediol Monohydrate, Levosulpiride, Luliconazole, Oxaceprol, Prucalopride Succinate, Teneligliptin Hydrobromide Hydrate, Vildagliptin, Fimasartan Trihydrate Potassium, Obeticholic Acid, Ursodeoxycholic Acid and others. Its Commercial KSMs, Intermediates and Reagents products include Ethyl-2-Amino 1,3-Thiazole 4-Carboxylate; 2,4,5-Trimethoxy Benzoic Acid; Ethyl 2-(2,4,5-trimethoxybenzamido)-1,3-thiazole-4-carboxylate; Choline phosphate chloride calcium, and others.